The Scientist

» drug development and disease/medicine

Most Recent

image: MicroRNAs Repair Heart Cells

MicroRNAs Repair Heart Cells

By | December 5, 2012

Researchers identify microRNAs that keep cardiac cells healthy after heart attack, potentially paving the way for future heart regenerating therapies.

1 Comment

image: New Mental Health Manual

New Mental Health Manual

By | December 5, 2012

Amid controversy, the American Psychiatric Association has approved the fifth edition of its guidebook on mental disorders.

1 Comment

image: Special Review for H5N1 Grants?

Special Review for H5N1 Grants?

By | December 4, 2012

The National Institutes of Health reveals a controversial plan to regulate the funding of H5N1 research.

0 Comments

image: Stem Cells from Blood

Stem Cells from Blood

By | December 3, 2012

Researchers develop a practical technique for deriving stem cells from routine blood samples.  

0 Comments

image: An Epi Phenomenon

An Epi Phenomenon

By | December 1, 2012

While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.

5 Comments

image: Contributors

Contributors

By | December 1, 2012

Meet some of the people featured in the December 2012 issue of The Scientist.

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

A protein called Coco rouses dormant breast cancer cells in the lung.

0 Comments

image: Can Worms Alleviate Autism?

Can Worms Alleviate Autism?

By | November 27, 2012

Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.

10 Comments

image: Neurologist Reveals Insider Information

Neurologist Reveals Insider Information

By | November 26, 2012

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

1 Comment

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham